Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Human papilloma virus (HPV) vaccine, 2-valent (types 16 and 18)

Generic name
Human papilloma virus (HPV) vaccine, 2-valent (types 16 and 18)
Brand name
ATC Code
J07BM02

Pharmacokinetics in children

No information

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Available formulations

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Dosages

NATIONAL VACCINATION PROGRAMME: HPV (human papilloma virus types 16 and 18)
  • Intramuscular
    • Girls 12 years
      [1] [2]
      • 0.5 ml/dose 2 vaccinations, as follows:. First vaccination: 12 years
        second vaccination: 6 months after the first vaccination.
HPV vaccination (human papilloma virus types 16 and 18)
  • Intramuscular
    • ≥ 9 years
      [2]

      • Vaccination schedule as per product information as follows: 0.5 ml/dose

        9 to15 years: 2 doses. The second dose is given at between 5 and 13 months after the first dose (if the second dose of vaccine is administered within 5 months after the first dose, a third dose must always be administered)
        > 15 years: 3 doses at 0, 1 and 6 months (the second dose may be administered between 1 and 2.5 months after the first dose; the third dose 5-12 months after the first dose.)

         

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Encephalitis vaccines
J07BA02
J07BA01
Influenza vaccines
J07BB02
Hepatitis vaccines
J07BC20
J07BC02
J07BC01
Measles vaccines
J07BD52
Poliomyelitis vaccines
J07BF03
Rabies vaccines
J07BG01
Rota virus diarrhea vaccines
J07BH01
Varicella zoster vaccines
J07BK01
Yellow fever vaccines
J07BL01
Papillomavirus vaccines
J07BM03
Other viral vaccines
J07BX04

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

References

  1. RijksInstituut voor Volksgezondheid en Milieu (RIVM), Rijksvaccinatieprogramma: vaccinatieschema versie 1.0 , 18 dec 2020
  2. GlaxoSmithKline BV, SmPC Cervarix, (EU/1/07/419) rev 33, 23-06-2020, www.ema.europa.eu

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Changes

Changes